LSE:HLN
LSE:HLNPersonal Products

Haleon (LSE:HLN) Eyes Bolt-On M&A and New Product Launches to Drive Growth Despite High Valuation Concerns

Haleon (LSE:HLN) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights include a 4.1% organic sales growth in Q2 2024 and the launch of new products, contrasted by a 4.4% decline in the over-the-counter pain relief category and regulatory risks. In the discussion that follows, we will delve into Haleon's financial health, operational inefficiencies, strategic growth initiatives, and external threats to provide a comprehensive overview of the...